- Home
- /
- Drugs
- /
- L
- /
- Lacosamide
- /
- LACOSAMIDE LACOSAMIDE 10 mg/mL Zydus Lifesciences Limited
LACOSAMIDE
- Lacosamide LACOSAMIDE 10 mg/mL Gland Pharma Limited
- LACOSAMIDE LACOSAMIDE 10 mg/mL XLCare Pharmaceuticals Inc.
- LACOSAMIDE LACOSAMIDE 10 mg/mL Zydus Pharmaceuticals USA Inc.
- LACOSAMIDE LACOSAMIDE 10 mg/mL Camber Pharmaceuticals, Inc.
- LACOSAMIDE LACOSAMIDE 10 mg/mL Zydus Pharmaceuticals USA Inc.
- Lacosamide LACOSAMIDE 10 mg/mL Novadoz Pharmaceuticals LLC
- Lacosamide LACOSAMIDE 10 mg/mL Fresenius Kabi USA, LLC
- LACOSAMIDE LACOSAMIDE 10 mg/mL Zydus Pharmaceuticals USA Inc.
- Lacosamide LACOSAMIDE 10 mg/mL Fosun Pharma USA
- LACOSAMIDE LACOSAMIDE 10 mg/mL Camber Pharmaceuticals, Inc.
- Vimpat LACOSAMIDE 10 mg/mL UCB, Inc.
- LACOSAMIDE LACOSAMIDE 10 mg/mL Zydus Pharmaceuticals USA Inc.
- LACOSAMIDE LACOSAMIDE 10 mg/mL Northstar Rx LLC.
- LACOSAMIDE LACOSAMIDE 10 mg/mL Zydus Lifesciences Limited
- LACOSAMIDE LACOSAMIDE 10 mg/mL Northstar Rx LLC.
- Vimpat LACOSAMIDE 10 mg/mL UCB, Inc.
- Lacosamide LACOSAMIDE 10 mg/mL Fosun Pharma USA
Summary of product characteristics
Effective Time
20231003
Version
2
Spl Product Data Elements
LACOSAMIDE Lacosamide LACOSAMIDE LACOSAMIDE HYDROCHLORIC ACID SODIUM CHLORIDE WATER
Application Number
ANDA209465
Brand Name
LACOSAMIDE
Generic Name
Lacosamide
Product Ndc
70771-1682
Product Type
HUMAN PRESCRIPTION DRUG
Route
INTRAVENOUS
Package Label Principal Display Panel
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1682-1 Lacosamide Injection, USP 200 mg/20 mL (10 mg/mL); CV For Intravenous Use Only 20 mL single-dose vial Rx only NDC 70771-1682-6 Lacosamide Injection, USP 200 mg/20 mL (10 mg/mL); CV For Intravenous Use Only 10 X 20 mL Single-dose vials Rx only vial label carton label
Spl Medguide
SPL MEDGUIDE
Drug section
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.